Finance

Lists
NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
၆၈.၃၅ US$
-၀.၃၅%
(-၀.၂၄) 1D
အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVZMY...
Open
၆၈.၃၄ US$
High
၆၈.၇၂ US$
Low
၆၈.၀၀ US$
Mkt. cap
ဋေ ၁.၉၀ သ
Avg. vol.
၂.၃၄ သောင်း
Volume
၁.၇၄ သောင်း
52-wk high
၇၅.၂၆ US$
52-wk low
၄၉.၉၀ US$
Beta
၀.၈၇
Shares outstanding
၄၁.၄၆ ကုဋေ
No. of employees
၁ သောင်း
Open
၆၈.၃၄ US$
High
၆၈.၇၂ US$
Low
၆၈.၀၀ US$
Mkt. cap
ဋေ ၁.၉၀ သ
Avg. vol.
၂.၃၄ သောင်း
Volume
၁.၇၄ သောင်း
52-wk high
၇၅.၂၆ US$
52-wk low
၄၉.၉၀ US$
Beta
၀.၈၇
Shares outstanding
၄၁.၄၆ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
finchannel
finchannel
·
ပြီးခဲ့သည့် ၂၁ မိနစ်
Apollo Commercial Real Estate Finance expects final NYSE trading on November 6
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၁ မိနစ်
Mobile Wallet Payouts Change The Bull Case For DLocal (DLO)
CNN
CNN
·
ပြီးခဲ့သည့် ၁၃ နာရီ
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
Novozymes A/S is a Danish biotechnology company. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy. The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations. The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings, which is owned by the Novo Nordisk Foundation. As of 2025, Novonesis has approximately 11,600 employees and activities in over 45 countries. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
CEOEster Baiget
Employees၁.၁၁ သောင်း
Founded၂၀၀၀
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
Google အက်ပ်များ